93 related articles for article (PubMed ID: 8752144)
1. Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression.
Francia G; Mitchell SD; Moss SE; Hanby AM; Marshall JF; Hart IR
Cancer Res; 1996 Sep; 56(17):3855-8. PubMed ID: 8752144
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display.
Hashimoto Y; Shindo-Okada N; Tani M; Takeuchi K; Toma H; Yokota J
Cancer Res; 1996 Nov; 56(22):5266-71. PubMed ID: 8912867
[TBL] [Abstract][Full Text] [Related]
3. CTp11, a novel member of the family of human cancer/testis antigens.
Zendman AJ; Cornelissen IM; Weidle UH; Ruiter DJ; van Muijen GN
Cancer Res; 1999 Dec; 59(24):6223-9. PubMed ID: 10626816
[TBL] [Abstract][Full Text] [Related]
4. Genes differentially expressed with malignant transformation and metastatic tumor progression of murine squamous cell carcinoma.
Dong G; Loukinova E; Smith CW; Chen Z; Van Waes C
J Cell Biochem Suppl; 1997; 28-29():90-100. PubMed ID: 9589353
[TBL] [Abstract][Full Text] [Related]
5. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.
Duncan LM; Deeds J; Hunter J; Shao J; Holmgren LM; Woolf EA; Tepper RI; Shyjan AW
Cancer Res; 1998 Apr; 58(7):1515-20. PubMed ID: 9537257
[TBL] [Abstract][Full Text] [Related]
7. AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation.
Madireddi MT; Dent P; Fisher PB
J Cell Physiol; 2000 Oct; 185(1):36-46. PubMed ID: 10942517
[TBL] [Abstract][Full Text] [Related]
8. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.
Neef R; Kuske MA; Pröls E; Johnson JP
Cancer Res; 2002 Oct; 62(20):5920-9. PubMed ID: 12384558
[TBL] [Abstract][Full Text] [Related]
9. Identification by differential display of a protein phosphatase-2A regulatory subunit preferentially expressed in malignant melanoma cells.
Francia G; Poulsom R; Hanby AM; Mitchell SD; Williams G; Mckee P; Hart IR
Int J Cancer; 1999 Aug; 82(5):709-13. PubMed ID: 10417769
[TBL] [Abstract][Full Text] [Related]
10. Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display.
Manda R; Kohno T; Matsuno Y; Takenoshita S; Kuwano H; Yokota J
Genomics; 1999 Oct; 61(1):5-14. PubMed ID: 10512675
[TBL] [Abstract][Full Text] [Related]
11. Loss of EphB6 expression in metastatic melanoma.
Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T
Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
[TBL] [Abstract][Full Text] [Related]
13. Isolation of a novel Sry-related gene that is expressed in high-metastatic K-1735 murine melanoma cells.
Tani M; Shindo-Okada N; Hashimoto Y; Shiroishi T; Takenoshita S; Nagamachi Y; Yokota J
Genomics; 1997 Jan; 39(1):30-7. PubMed ID: 9027483
[TBL] [Abstract][Full Text] [Related]
14. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
15. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
16. RB1 oncosuppressor gene over-expression inhibits tumor progression and induces melanogenesis in metastatic melanoma cells.
Valente P; Melchiori A; Paggi MG; Masiello L; Ribatti D; Santi L; Takahashi R; Albini A; Noonan DM
Oncogene; 1996 Sep; 13(6):1169-78. PubMed ID: 8808691
[TBL] [Abstract][Full Text] [Related]
17. Expression and Up-regulation of alternatively spliced transcripts of melastatin, a melanoma metastasis-related gene, in human melanoma cells.
Fang D; Setaluri V
Biochem Biophys Res Commun; 2000 Dec; 279(1):53-61. PubMed ID: 11112417
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
19. Expression of thyrotropin-releasing hormone by human melanoma and nevi.
Ellerhorst JA; Naderi AA; Johnson MK; Pelletier P; Prieto VG; Diwan AH; Johnson MM; Gunn DC; Yekell S; Grimm EA
Clin Cancer Res; 2004 Aug; 10(16):5531-6. PubMed ID: 15328193
[TBL] [Abstract][Full Text] [Related]
20. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
